1. THE ROLE OF THE PATHOLOGIST IN TARGETED THERAPY & PERSONALIZED MEDICINE Dr Dinah Parums, Principal Pathologist, 2007 2. WHAT ARE THE COMPONENTS OF A PATHOLOGY CAPABILITY…

1. © 2011 TRIO GRUP 2. TRIO GRUP CLINICALRESEARCH (CRO)Established in 2011TRIO GRUP headquarter is in Ankara, TURKEYApproved by Turkish regulatory authority Ministry…

Optimizing Patient Enrollment in Clinical Trials Forum Objectives Discuss enrollment strategies Highlight important factors Share ideas Maximize impact on outcome Create…

1. Innovation: Key to Organic Growth Jay RaoProfessor Babson 2. Setting Expectations• I will not discuss every slide / bullet point.• You will receive all presentations…

1. Four practical approaches to managing a more effective device trial Blair Keagy, MD, CEO, Medical Products Analytics David Levin, Vice President, Clinipace June 10, 2009…

1. Anand S. Patel MD*, Wyatt M. Tellis PhD, Mary Torosyan,David E. Avrin MD PhD, and Ronald L. Arenson, MDUCSF Department of Radiology and Biomedical ImagingLaboratory for…

1. 1 LEADING REGENERATIVE MEDICINE 2. 2 Cautionary Statement Concerning Forward-Looking Statements This presentation is intended to present a summary of ACT’s (“ACT”,…

1. 1 LEADING REGENERATIVE MEDICINE 2013 Annual Global Investment Conference 2. 2 Cautionary Statement Concerning Forward-Looking Statements This presentation is intended…

Slide 1Impact of Velaglucerase Alfa Therapy on Bone Marrow Burden Score in Adults with Type 1 Gaucher Disease: 7-Year Experience Deborah Elstein; 1 Andrew H. Haims; 2 David…

Slide 1An Aid to Cost-Effectively Delivering The right care at the right time Optimizing health care system resources for implantable cardiac device patients though technology…